Mefenamic acid: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:
{{EH}}
{{EH}}


==Overview==
'''Mefenamic acid''' is a [[NSAID|non-steroidal anti-inflammatory drug]] used to treat pain, including [[menstruation|menstrual]] pain. It is commercially available in the US as '''Ponstel®''' and internationally by [[Pfizer]] as '''Ponstan®'''. It is also prescribed as an [[antipyretic]] drug. It is typically prescribed for oral administration.  
'''Mefenamic acid''' is a [[NSAID|non-steroidal anti-inflammatory drug]] used to treat pain, including [[menstruation|menstrual]] pain. It is commercially available in the US as '''Ponstel®''' and internationally by [[Pfizer]] as '''Ponstan®'''. It is also prescribed as an [[antipyretic]] drug. It is typically prescribed for oral administration.  



Revision as of 17:41, 11 June 2009

Mefenamic acid
Clinical data
Pregnancy
category
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • ℞-only (U.S.)
Pharmacokinetic data
Bioavailability90%
Protein binding90%
MetabolismHepatic (CYP2C9)
Elimination half-life2 hours
ExcretionRenal and fecal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H15NO2
Molar mass241.285 g/mol

WikiDoc Resources for Mefenamic acid

Articles

Most recent articles on Mefenamic acid

Most cited articles on Mefenamic acid

Review articles on Mefenamic acid

Articles on Mefenamic acid in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mefenamic acid

Images of Mefenamic acid

Photos of Mefenamic acid

Podcasts & MP3s on Mefenamic acid

Videos on Mefenamic acid

Evidence Based Medicine

Cochrane Collaboration on Mefenamic acid

Bandolier on Mefenamic acid

TRIP on Mefenamic acid

Clinical Trials

Ongoing Trials on Mefenamic acid at Clinical Trials.gov

Trial results on Mefenamic acid

Clinical Trials on Mefenamic acid at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mefenamic acid

NICE Guidance on Mefenamic acid

NHS PRODIGY Guidance

FDA on Mefenamic acid

CDC on Mefenamic acid

Books

Books on Mefenamic acid

News

Mefenamic acid in the news

Be alerted to news on Mefenamic acid

News trends on Mefenamic acid

Commentary

Blogs on Mefenamic acid

Definitions

Definitions of Mefenamic acid

Patient Resources / Community

Patient resources on Mefenamic acid

Discussion groups on Mefenamic acid

Patient Handouts on Mefenamic acid

Directions to Hospitals Treating Mefenamic acid

Risk calculators and risk factors for Mefenamic acid

Healthcare Provider Resources

Symptoms of Mefenamic acid

Causes & Risk Factors for Mefenamic acid

Diagnostic studies for Mefenamic acid

Treatment of Mefenamic acid

Continuing Medical Education (CME)

CME Programs on Mefenamic acid

International

Mefenamic acid en Espanol

Mefenamic acid en Francais

Business

Mefenamic acid in the Marketplace

Patents on Mefenamic acid

Experimental / Informatics

List of terms related to Mefenamic acid

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is commercially available in the US as Ponstel® and internationally by Pfizer as Ponstan®. It is also prescribed as an antipyretic drug. It is typically prescribed for oral administration.

Mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism. However it is thought to be related to the inhibition of prostaglandin synthesis.


Since hepatic metabolism plays a significant role in mefenamic acid elimination, patients with known liver deficiency may be prescribed lower doses. Kidney deficiency may also cause accumulation of the drug and its metabolites in the excretory system. Therefore patients suffering from renal conditions should not be prescribed mefenamic acid.

Side effects

Mefenamic acid is known to cause an upset stomach, therefore it is recommended to take prescribed doses together with food or milk. Instances of drowsiness may also occur. As such, it is recommended to avoid driving or consuming alcohol while taking this medication.

Other known mild side effects of mefenamic acid include headaches, nervousness and vomiting. Serious side effects may include diarrhoea, bloody vomit, blurred vision, skin rash, itching and swelling, sore throat and fever. It is advised to consult a doctor immediately if these symptoms appear while taking this medication.

Sources

Template:SIB de:Mefenaminsäure

Template:WH Template:WikiDoc Sources